Despite the introduction of more than one dozen new antiepileptic drugs in the past 20 years, approximately one-third of people who develop epilepsy continue to have seizures on mono- or polytherapy1. Viral-vector-mediated gene transfer offers the opportunity to design a rational treatment that builds on mechanistic understanding of seizure generation and that can be targeted to specific neuronal populations in epileptogenic foci2. Several such strategies have shown encouraging results in different animal models, although clinical translation is limited by possible effects on circuits underlying cognitive, mnemonic, sensory or motor function. Here, we describe an autoregulatory antiepileptic gene therapy, which relies on neuronal inhibition in response to elevations in extracellular glutamate. It is effective in a rodent model of focal epilepsy and is well tolerated, thus lowering the barrier to clinical translation.
This is a preview of subscription content, access via your institution
Subscribe to Nature+
Get immediate online access to Nature and 55 other Nature journal
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Chen, Z., Brodie, M. J., Liew, D. & Kwan, P. Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: a 30-year longitudinal cohort study. JAMA Neurol. 75, 279–286 (2018).
Kullmann, D. M., Schorge, S., Walker, M. C. & Wykes, R. C. Gene therapy in epilepsy-is it time for clinical trials? Nat. Rev. Neurol. 10, 300–304 (2014).
Kwan, P., Schachter, S. C. & Brodie, M. J. Drug-resistant epilepsy. N. Engl. J. Med. 365, 919–926 (2011).
Tang, F., Hartz, A. M. S. & Bauer, B. Drug-resistant epilepsy: multiple hypotheses, few answers. Front. Neurol. 8, 301 (2017).
Perucca, P. & Gilliam, F. G. Adverse effects of antiepileptic drugs. Lancet Neurol. 11, 792–802 (2012).
Ryvlin, P., Cross, J. H. & Rheims, S. Epilepsy surgery in children and adults. Lancet Neurol. 13, 1114–1126 (2014).
Wykes, R. C. et al. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy. Sci. Transl. Med. 4, 161ra152 (2012).
Kätzel, D., Nicholson, E., Schorge, S., Walker, M. C. & Kullmann, D. M. Chemical-genetic attenuation of focal neocortical seizures. Nat. Commun. 5, 3847 (2014).
Cook, M. J. et al. Prediction of seizure likelihood with a long-term, implanted seizure advisory system in patients with drug-resistant epilepsy: a first-in-man study. Lancet Neurol. 12, 563–571 (2013).
Baldassano, S. N. et al. Crowdsourcing seizure detection: algorithm development and validation on human implanted device recordings. Brain 140, 1680–1691 (2017).
Buckingham, S. C. et al. Glutamate release by primary brain tumors induces epileptic activity. Nat. Med. 17, 1269–1274 (2011).
During, M. J. & Spencer, D. D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 341, 1607–1610 (1993).
Stephens, M. L. et al. Tonic glutamate in CA1 of aging rats correlates with phasic glutamate dysregulation during seizure. Epilepsia 55, 1817–1825 (2014).
Cavus, I. et al. 50 Hz hippocampal stimulation in refractory epilepsy: higher level of basal glutamate predicts greater release of glutamate. Epilepsia 57, 288–297 (2016).
Thomas, P. M., Phillips, J. P. & O’Connor, W. T. Hippocampal microdialysis during spontaneous intraoperative epileptiform activity. Acta Neurochir. (Wien.) 146, 143–151 (2004).
Frazier, S. J., Cohen, B. N. & Lester, H. A. An engineered glutamate-gated chloride (GluCl) channel for sensitive, consistent neuronal silencing by ivermectin. J. Biol. Chem. 288, 21029–21042 (2013).
Yaguchi, M. et al. Characterization of the properties of seven promoters in the motor cortex of rats and monkeys after lentiviral vector-mediated gene transfer. Hum. Gene Ther. Methods 24, 333–344 (2013).
Barker-Haliski, M. & White, H. S. Glutamatergic mechanisms associated with seizures and epilepsy. Cold Spring Harb. Perspect. Med. 5, a022863 (2015).
Tzingounis, A. V. & Wadiche, J. I. Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Nat. Rev. Neurosci. 8, 935–947 (2007).
Vink, C. A. et al. Eliminating HIV-1 packaging sequences from lentiviral vector proviruses enhances safety and expedites gene transfer for gene therapy. Mol. Ther. 25, 1790–1804 (2017).
Mainardi, M., Pietrasanta, M., Vannini, E., Rossetto, O. & Caleo, M. Tetanus neurotoxin-induced epilepsy in mouse visual cortex. Epilepsia 53, e132–e136 (2012).
Cleeren, E., Casteels, C., Goffin, K., Janssen, P. & Van Paesschen, W. Ictal perfusion changes associated with seizure progression in the amygdala kindling model in the rhesus monkey. Epilepsia 56, 1366–1375 (2015).
Weir, G. A. et al. Using an engineered glutamate-gated chloride channel to silence sensory neurons and treat neuropathic pain at the source. Brain 140, 2570–2585 (2017).
Jaenisch, N. et al. Reduced tonic inhibition after stroke promotes motor performance and epileptic seizures. Sci. Rep. 6, 26173 (2016).
Asztely, F., Erdemli, G. & Kullmann, D. M. Extrasynaptic glutamate spillover in the hippocampus: dependence on temperature and the role of active glutamate uptake. Neuron 18, 281–293 (1997).
Cavus, I. et al. Extracellular metabolites in the cortex and hippocampus of epileptic patients. Ann. Neurol. 57, 226–235 (2005).
Miles, R., Blaesse, P., Huberfeld, G., Wittner, L. & Kaila, K. Chloride homeostasis and GABA signaling in temporal lobe epilepsy. in Jasper’s Basic Mechanisms of the Epilepsies (eds. Noebels, J. L. et al.) (National Center for Biotechnology Information, Bethesda, MD, USA, 2012).
Bolte, S. & Cordelières, F. P. A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 224, 213–232 (2006).
We thank G. Schiavo (UCL Institute of Neurology) for the gift of tetanus toxin and S. Hart (UCL Institute of Child Health) for the mouse Neuro-2a cell line. We are grateful to J. Cornford for assistance with ECoG analysis and to K. Hashemi for help optimizing wireless-transmitter use. This project was supported by the European Union’s Horizon 2020 research and innovation program (Marie Skłodowska-Curie grant agreement no. 701411 to A.L.); the Medical Research Council (MR/L01095X/1 to D.M.K., S.S. and M.C.W.); and the Wellcome Trust (095580/Z/11/Z to D.M.K.; 104033/Z/14/Z to D.M.K. and S.S.).
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Lieb, A., Qiu, Y., Dixon, C.L. et al. Biochemical autoregulatory gene therapy for focal epilepsy. Nat Med 24, 1324–1329 (2018). https://doi.org/10.1038/s41591-018-0103-x
This article is cited by
Cellular and Molecular Neurobiology (2022)
Gene Therapy Approach with an Emphasis on Growth Factors: Theoretical and Clinical Outcomes in Neurodegenerative Diseases
Molecular Neurobiology (2022)
Gene Therapy (2019)
Nature Reviews Drug Discovery (2018)